“Novel Therapies for Diabetes and Kidney Disease – Revolutionizing Treatment for Two of Our Most Deadly Chronic Diseases”

Jeffrey Millman: “Improving Diabetes Healthcare with Stem Cell Technologies “
Mohamed Zayed: “Novel Intra-Vascular Cell and Drug-Eluting Delivery Platform”

Join the Zoom Webinar at vencafstl.org/virtual/

SPEAKERS
Jeffrey Millman, Ph.D.
Assistant Professor of Medicine & Biomedical Engineering
“Improving Diabetes Healthcare with Stem Cell Technologies “
Summary: Healthcare costs for treating diabetes are over $42 billion per year, with persistence of long-term complications still a remaining major challenge in patient care. This seminar will discuss how the generation of insulin-producing cells from stem cells for use in drug screening and cell replacement therapy can revolutionize next generation treatment for patients.

Mohamed Zayed, MD, PhD, FASC
Assistant Professor, Vascular Surgery, Division of General Surgery
“Novel Intra-Vascular Cell and Drug-Eluting Delivery Platform”
Summary: Arteriovenous grafts have been used for decades to facilitate hemodialysis. They are directly attached to a person’s vasculature. So why not use them as a cell and drug-delivery platform?

For additional info, visit the ICTS website. 

The Institute of Clinical and Translational Sciences (ICTS) Precision Medicine team invites you to an on-going collaboration with Venture Café.  On the third Thursday of every month , ICTS Precision Medicine hosts a session featuring WashU faculty working in translational genomics/precision medicine areas. Talks are typically oriented toward biotechnology, diagnostics, informatics, start-ups and precision interventions based on medical genomics innovations.